BioLineRx and Hemispherian Announce Two GLIX1 Presentations at the 31st Society for Neuro-Oncology (SNO) Annual Meeting & Education Day

Summary

BioLineRx and Hemispherian announced two presentations of GLIX1 at the 31st Society for Neuro-Oncology Annual Meeting. The announcement represents a routine conference disclosure with limited material impact.